Profile
Full Name
Ironwood Pharmaceuticals, Inc.Ticker Symbol
IRWDExchange
NASDAQSector
HealthcareCountry
United StatesIPO
February 3, 2010Indexes
Not includedWebsite
http://ironwoodpharma.comEmployees
253Key Details
Price
$0.75(+0.36%)
Market cap
$121.79M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$351.41M(-20.63% YoY)
Annual EPS
$0.01(+100.16% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Ironwood Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 14, 25 Leerink Partners
Market PerformJan 30, 25 JMP Securities
Market OutperformJan 22, 25 Craig-Hallum
BuySep 9, 24 Leerink Partners
Market PerformAug 9, 24 Wells Fargo
OverweightAug 9, 24 Craig-Hallum
BuyMay 10, 24 Craig-Hallum
BuyMar 1, 24 Wells Fargo
OverweightFeb 16, 24 Piper Sandler
OverweightJan 17, 24 Craig-Hallum
BuyInstitutional Ownership
- What is the ticker symbol for Ironwood Pharmaceuticals?
- Does Ironwood Pharmaceuticals pay dividends?
- What sector is Ironwood Pharmaceuticals in?
- What industry is Ironwood Pharmaceuticals in?
- What country is Ironwood Pharmaceuticals based in?
- When did Ironwood Pharmaceuticals go public?
- Is Ironwood Pharmaceuticals in the S&P 500?
- Is Ironwood Pharmaceuticals in the NASDAQ 100?
- Is Ironwood Pharmaceuticals in the Dow Jones?
- When was Ironwood Pharmaceuticals's last earnings report?
- When does Ironwood Pharmaceuticals report earnings?
- Should I buy Ironwood Pharmaceuticals stock now?
What is the ticker symbol for Ironwood Pharmaceuticals?
The ticker symbol for Ironwood Pharmaceuticals is NASDAQ:IRWD
Does Ironwood Pharmaceuticals pay dividends?
No, Ironwood Pharmaceuticals does not pay dividends
What sector is Ironwood Pharmaceuticals in?
Ironwood Pharmaceuticals is in the Healthcare sector
What industry is Ironwood Pharmaceuticals in?
Ironwood Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is Ironwood Pharmaceuticals based in?
Ironwood Pharmaceuticals is headquartered in United States
When did Ironwood Pharmaceuticals go public?
Ironwood Pharmaceuticals's initial public offering (IPO) was on February 3, 2010
Is Ironwood Pharmaceuticals in the S&P 500?
No, Ironwood Pharmaceuticals is not included in the S&P 500 index
Is Ironwood Pharmaceuticals in the NASDAQ 100?
No, Ironwood Pharmaceuticals is not included in the NASDAQ 100 index
Is Ironwood Pharmaceuticals in the Dow Jones?
No, Ironwood Pharmaceuticals is not included in the Dow Jones index
When was Ironwood Pharmaceuticals's last earnings report?
Ironwood Pharmaceuticals's most recent earnings report was on Feb 27, 2025
When does Ironwood Pharmaceuticals report earnings?
The next expected earnings date for Ironwood Pharmaceuticals is May 9, 2025
Should I buy Ironwood Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions